Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors : Identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist
Drugs that antagonize D2-like receptors are effective antipsychotics, but the debilitating movement disorder side effects associated with these drugs cannot be dissociated from dopamine receptor blockade. The "atypical" antipsychotics have a lower propensity to cause extrapyramidal symptoms (EPS), but the molecular basis for this is not fully understood nor is the impact of inverse agonism upon th